Last reviewed · How we verify

TTRNA-DC vaccines with GM-CSF

University of Florida · Phase 1 active Biologic Quality 0/100

TTRNA-DC vaccines with GM-CSF is a Biologic drug developed by University of Florida. It is currently in Phase 1 development.

At a glance

Generic nameTTRNA-DC vaccines with GM-CSF
SponsorUniversity of Florida
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about TTRNA-DC vaccines with GM-CSF

What is TTRNA-DC vaccines with GM-CSF?

TTRNA-DC vaccines with GM-CSF is a Biologic drug developed by University of Florida.

Who makes TTRNA-DC vaccines with GM-CSF?

TTRNA-DC vaccines with GM-CSF is developed by University of Florida (see full University of Florida pipeline at /company/university-of-florida).

What development phase is TTRNA-DC vaccines with GM-CSF in?

TTRNA-DC vaccines with GM-CSF is in Phase 1.

Related